Clinical Trial of Ebola Vaccine Regimen in Sierra Leone
Johnson & Johnson (NYSE: JNJ) announced Friday the start of a safety and immunogenicity clinical trial in Sierra Leone of
Read moreJohnson & Johnson (NYSE: JNJ) announced Friday the start of a safety and immunogenicity clinical trial in Sierra Leone of
Read moreAs the Ebola outbreak continues to cause concern, Nurse.com and the Johnson & Johnson Campaign for Nursing’s Future have launched
Read moreA new contest aims to bring three lucky fans of singing star Charice a trip to Los Angeles to be
Read more